Concurrent chemotherapy and radiation therapy in the treatment of childhood and adolescent Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000505:Alopecia / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006413:Hematopoietic System / Q000187:drug effects; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007239:Infections / Q000150:complications; D008297:Male; D009748:Nutrition Disorders / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use*; D011344:Procarbazine / Q000009:adverse effects / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use*
D003037:Cobalt Radioisotopes; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone